NCT01466478View on ClinicalTrials.gov

An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Psoriasis Vulgaris

Interventions

DRUG

Ointment A: LEO 29102 2.5 mg/g plus calcipotriol 50 µg/g ointment

once daily application, 4 weeks

DRUG

Ointment B: LEO 29102 2.5 mg/g ointment

once daily application, 4 weeks

DRUG

Ointment C: Calcipotriol 50 µg/g ointment

once daily application, 4 weeks

DRUG

Ointment D: LEO 29102 2.5 mg/g plus calcipotriol 50 µg/g ointment

once daily application, 4 weeks

DRUG

Ointment G: LEO 29102 2.5 mg/g plus calcipotriol 50 µg/g ointment

once daily application, 4 weeks

DRUG

Daivonex® ointment

once daily application, 4 weeks

DRUG

Diprosone® ointment

once daily application, 4 weeks

Trial Locations (1)

06202

CPCAD - Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Nice

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY